Athira Pharma Inc.

ATHA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.75

-$0.44 (-6.12%)

At close: Jan 09, 2026, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $26.62M

Enterprise Value $-23.87M

Beta 2.80

Average Volume N/A

Shares Outstanding (Diluted) 23.73M

Shares Change YoY 506.92%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -35.3%

1Y CAGR (ann.) -7.0%

5Y CAGR (ann.) -53.2%

All-Time CAGR -48.5%

Valuation

PE Ratio -0.29

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 0.79

P/FCF Ratio -0.43

P/Adj. FCF Ratio -0.39

P/OCF Ratio -2.59

EV/Sales N/A

EV/EBIT -1.48

EV/EBITDA 1.18

EV/FCF 0.39

Earnings Yield -343.0%

FCF Yield -232.6%

Adj. FCF Yield -257.8%

Financial Health

Net Cash $50.49M

Total Debt $577K

Cash & Short-Term Investments $51.07M

Total Assets $56.89M

Current Ratio 7.01

Quick Ratio 7.01

Debt / Equity Ratio 0.02

Debt / EBITDA -0.03

Debt / FCF -0.01

OCF / Debt -107.32

Interest Coverage 0.00

Altman Z-Score -11.26

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -10.8%

Returns

Return on Assets -248.6%

Return on Equity -411.6%

Return on Invested Capital -246.3%

Return on Capital Employed -248.8%

Return on Tangible Assets -248.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 14.6%

EPS CAGR 5Y 1.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y 23.7%

FCF CAGR 5Y 3.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 5

EPS Growth Next 3Y 32.7%

Revenue Growth Next 3Y N/A

Earnings Date Aug 13, 2026

EPS Estimate (next Q) -$0.60

EPS Growth Est (next Q) -66.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $13.33

Price Target Upside 97.5%

Cash Flow

Operating Cash Flow $-61.93M

Free Cash Flow $-61.93M

Adj. Free Cash Flow $-68.64M

FCF Per Share -$2.61

OCF Per Share -$2.61

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-67.65M

Operating Income $-122.11M

EBITDA $-20.21M

Net Income $-141.46M

EPS (Diluted) -$23.15

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A